August 2015 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2014/15 Invitation to Tender, dated 6 November 2014.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2014/15 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2018
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) |
Date of subsidy change | Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
| Domperidone | Tab 10 mg; 100 tablets, blister pack |
$3.25 | $3.20 | Prokinex (Airflow) |
1 October 2015 | 1 January 2016 |
| Oxycodone hydrochloride | Inj 50 mg per ml, 1 ml ampoule; 5 ampoules |
$60.00 | $51.00 | OxyNorm (Mundipharma) |
1 October 2015 | 1 January 2016 |
Tenders awarded to currently listed pharmaceuticals where at least one other brand is listed
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) | New subsidy (and price) | Sole supply brand (Supplier) | Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Oxycodone hydrochloride | Inj 10 mg per ml, 1 ml ampoule; 5 ampoules |
$10.08 | $8.57 | OxyNorm (Mundipharma) |
1 December 2015 | 1 February 2016 | 1 May 2016 | Oxycodone Orion (Max Health) |
| Oxycodone hydrochloride | Inj 10 mg per ml, 2 ml ampoule; 5 ampoules |
$19.87 | $16.89 | OxyNorm (Mundipharma) |
1 December 2015 | 1 February 2016 | 1 May 2016 | Oxycodone Orion (Max Health) |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) |
New subsidy (and price) |
Hospital Supply Brand (Supplier) |
DV Limit |
Date of subsidy change | Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
| Domperidone | Tab 10 mg; 100 tablets, blister pack |
$3.25 | $3.20 | Prokinex (Airflow) |
1% | 1 October 2015 | 1 December 2015 |
| Oxycodone hydrochloride | Inj 50 mg per ml, 1 ml ampoule; 5 ampoules |
$60.00 | $51.00 | OxyNorm (Mundipharma) |
1% | 1 October 2015 | 1 December 2015 |
Tenders awarded to pharmaceuticals where at least one other brand is listed
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current subsidy (and price) |
New subsidy (and price) |
Hospital Supply Brand (Supplier) |
DV Limit | Listing date | Hospital Supply Status date |
Brand (Supplier) |
|---|---|---|---|---|---|---|---|---|
| Oxycodone hydrochloride | Inj 10 mg per ml, 1 ml ampoule; 5 ampoules |
$10.08 | $8.57 | OxyNorm (Mundipharma) |
1% | 1 December 2015 | 1 February 2016 | Oxycodone Orion (Max Health) |
| Oxycodone hydrochloride | Inj 10 mg per ml, 2 ml ampoule; 5 ampoules |
$19.87 | $16.89 | OxyNorm (Mundipharma) |
1% | 1 December 2015 | 1 February 2016 | Oxycodone Orion (Max Health) |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 7 November 2013, and the 2014/15 Invitation to Tender, dated 6 November 2014:
2013/14 Invitation to Tender
| Chemical name | Line item |
|---|---|
| Aciclovir | Eye oint 3% |
| Hyoscine N-butylbromide | Tab 10 mg |
| Ornidazole | Tab 500 mg |
| Thiopental [thiopentone] sodium | Inj 500 mg |
| Zinc | Crm BP |
| Zinc | Oint BP |
2014/15 Invitation to Tender
| Chemical name | Line Item |
|---|---|
| Brimonidine tartrate with timolol maleate | Eye drops 0.2% with timolol maleate 0.5% |
| Calcipotriol | Crm 50 mcg per g (pack size 30 g or less) |
| Calcipotriol | Crm 50 mcg per g (pack size greater than 30 g) |
| Calcipotriol | Oint 50 mcg per g (pack size 30 g or less) |
| Calcipotriol | Oint 50 mcg per g (pack size greater than 30 g) |
| Condoms | Latex-free 55 mm or greater |
| Fondaparinux sodium | Inj 2.5 mg syringe |
| Methadone hydrochloride | Inj 10 mg per ml, 1 ml |
| Pyrazinamide | Tab 500 mg |
| Trimethoprim with sulphamethoxazole [co-trimoxazole] | Tab trimethoprim 80 mg and sulphamethoxazole 400 mg |
For products included in the 2013/14 and 2014/15 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.